Atea Pharmaceuticals, Inc. — Investor Relations & Filings
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company leverages its expertise in virology, medicinal chemistry, and biology to develop direct-acting antivirals for single-stranded ribonucleic acid (ssRNA) viruses. Atea's lead program is a combination regimen of bemnifosbuvir (a nucleotide analog polymerase inhibitor) and ruzasvir (an NS5A inhibitor) for the treatment of Hepatitis C Virus (HCV). This oral, pan-genotypic regimen is currently in a global Phase 3 development program, aiming to address unmet medical needs for patients with HCV.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - Atea Pharmaceuticals, Inc. (0001593899) (Filer) | 2026-04-27 | English | |
| SCHEDULE 13G - Atea Pharmaceuticals, Inc. (0001593899) (Subject) | 2026-02-09 | English | |
| 4 Filing | 2026-02-03 | English | |
| 4 Filing | 2026-02-03 | English | |
| 4 Filing | 2026-02-03 | English | |
| 4 Filing | 2026-02-03 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 37630681 | DEF 14A - Atea Pharmaceuticals, Inc. (0001593899) (Filer) | 2026-04-27 | English | ||
| 18045213 | SCHEDULE 13G - Atea Pharmaceuticals, Inc. (0001593899) (Subject) | 2026-02-09 | English | ||
| 30793381 | 4 Filing | 2026-02-03 | English | ||
| 30793320 | 4 Filing | 2026-02-03 | English | ||
| 30793270 | 4 Filing | 2026-02-03 | English | ||
| 30793257 | 4 Filing | 2026-02-03 | English | ||
| 30793236 | 4 Filing | 2026-02-03 | English | ||
| 30793230 | 4 Filing | 2026-02-03 | English | ||
| 12731471 | 8-K | 2026-01-08 | English | ||
|
2025
6 filings
| |||||
| 12731473 | Major Shareholding Notification 2025 | 2025-12-05 | English | ||
| 12731470 | 10-Q | 2025-11-12 | English | ||
| 12731474 | 8-K | 2025-11-12 | English | ||
| 12731472 | S-8 | 2025-08-07 | English | ||
| 12731475 | 10-Q | 2025-08-07 | English | ||
| 12731476 | 8-K | 2025-08-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Atea Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33577/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33577 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33577 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33577 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33577}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Atea Pharmaceuticals, Inc. (id: 33577)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.